Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.

Moderna (NasdaqGS:MRNA) saw an 11% increase in share price over the last week, likely influenced by recent legal and financial developments. The announcement of multiple international lawsuits from ...

Moderna's litigation with its main COVID vaccine rivals dates back to August 2022, according to the company's recently released 2024 annual report/10-K submission: In August 2022, we filed a ...

CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 45th Annual Health ...

But these antics actually do serve a useful social and political purpose — for Trump’s fellow deep pockets and the ...

Tyson Foods CEO Donnie King has seen his annual executive rewards leap from $13 million in 2023 to $22.7 million in 2024. To ...

CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 45th Annual Health ...

The projected annual revenue for Moderna is 8,186MM ... Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider ...